The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma
This study will assess the clinical efficacy and safety of fluorouracil implants regional chemotherapy during the surgical treatment for early-stage hepatocellular carcinoma.
Early Stage Hepatocellular Carcinoma
PROCEDURE: Radical resection|DRUG: Fluorouracil Implants
To assess the clinical benefit of fluorouracil implants regional chemotherapy during the radical resection in early stage hepatocellular carcinoma patients. The primary endpoint is disease-free survival (DFS)., 1, 2, and 3 years
Quality of Life, from baseline to the last visit|Incidence Rate of Complications, 1, 2, and 3 years|Adverse Events, from the beginning of treatment to the end of study
This study will assess the clinical efficacy and safety of fluorouracil implants regional chemotherapy during the surgical treatment for early-stage hepatocellular carcinoma.